About Us Strategy & Mission Our Values Our People Our Board Our Collaborations Contact Our Programmes Overview Pipeline C. difficile Infection Enterobacteriaceae ESKAPE Programme Clinical Trials Stewardship Compassionate Use Our Science Discuva Platform Publications Investors Investor Centre Press Releases Financial Reports & Filings Email Alerts Events & Presentations Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
A Novel Small Molecule Antibiotic for the Treatment of Neisseria gonorrhoeae A Novel Small Molecule Antibiotic for the Treatment of Neisseria gonorrhoeae November 13, 2018 By Mary Alvarado
A Novel Small Molecule Antibiotic for the Treatment of Neisseria gonorrhoeae November 13, 2018 By Mary Alvarado